Drug companies have many tactics as their disposal to minimize supply chain disruptions for critical healthcare products, but should they shoulder all of the costs of doing so?
Drug companies have many tactics as their disposal to minimize supply chain disruptions for critical healthcare products, but should they shoulder all of the costs of doing so?